DAMPs and inflammatory processes: The role of redox in the different outcomes

Journal of Leukocyte Biology

Volumn 86, Issue 3, 2009, Pages 549-555

  Carta, Sonia ^a   Castellani, Patrizia ^a   Delfino, Laura ^a   Tassi, Sara ^a   Venè, Roberta ^a   Rubartelli, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

B lymphocytes; Cancer; Cysteine; IL 1 ; Oxidative stress; ROS

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; LECTIN; NUCLEAR PROTEIN; PROTEIN DAMP; PROTEIN S 100; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; B LYMPHOCYTE DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTIOXIDANTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 70149123249     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1008598     Document Type: Short Survey

References (80)

1. Akira, S., Takeda, K. (2004) Functions of Toll-like receptors: lessons from KO mice. C. R. Biol. 327, 581-589. (Pubitemid 38979508)
2. Seong, S. Y., Matzinger, P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478.
3. Oppenheim, J. J., Yang, D. (2005) Alarmins chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365.
4. Rhee, S. G. (2006) Cell signaling. H2O2, a necessary evil for cell signaling. Science 312, 1882-1883.
5. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84. (Pubitemid 44566469)
6. Storz, G., Toledano, M. B. (1994) Regulation of bacterial gene expression in response to oxidative stress. Methods Enzymol. 236, 196-207. (Pubitemid 24283614)
7. Fialkow, L., Wang, Y., Downey, G. P. (2007) Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 42, 153-164. (Pubitemid 46001554)
8. Shin, D. M., Yang, C. S., Lee, J. Y., Lee, S. J., Choi, H. H., Lee, H. M., Yuk, J. M., Harding, C. V., Jo, E. K. (2008) Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C ζ in lipid rafts contributes to reactive oxygen species-dependent inflammatory signaling in macrophages. Cell. Microbiol. 10, 1893-1905.
9. Yamamoto, S., Shimizu, S., Kiyonaka, S., Takahashi, N., Wajima, T., Hara, Y., Negoro, T., Hiroi, T., Kiuchi, Y., Okada, T., Kaneko, S., Lange, I., Fleig, A., Penner, R., Nishi, M., Takeshima, H., Mori, Y. (2008) TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat. Med. 14, 738-747. (Pubitemid 351953041)
10. Blüml, S., Rosc, B., Lorincz, A., Seyerl, M., Kirchberger, S., Oskolkova, O., Bochkov, V. N., Majdic, O., Ligeti, E., Stöckl, J. (2008) The oxidation state of phospholipids controls the oxidative burst in neutrophil granulocytes. J. Immunol. 181, 4347-4353.
11. Cooke, M. S., Evans, M. D., Dizdaroglu, M., Lunec, J. (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17, 1195-1214. (Pubitemid 36775767)
12. Moriarty-Craige, S. E., Jones, D. P. (2004) Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 24, 481-509.
13. Rubartelli, A., Sitia, R. (2009) Stress as an intercellular signal: the emergence of stress associated molecular patterns (SAMP). Antioxid. Redox Signal., Epub ahead of print.
14. Jordan, P. A., Stevens, J. M., Hubbard, G. P., Barrett, N. E., Sage, T., Authi, K. S., Gibbins, J. M. (2005) A role for the thiol isomerase protein ERP5 in platelet function. Blood 105, 1500-1507. (Pubitemid 40223666)
15. Lahav, J., Jurk, K., Hess, O., Barnes, M. J., Farndale, R. W., Luboshitz, J., Kehrel, B. E. (2002) Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 100, 2472-2478.
16. Reinhardt, C., von Bruhl, M. L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., Mackman, N., Ruddock, L., Massberg, S., Engelmann, B. (2008) Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J. Clin. Invest. 118, 1110-1122.
17. Ahamed, J., Versteeg, H. H., Kerver, M., Chen, V. M., Mueller, B. M., Hogg, P. J., Ruf, W. (2006) Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl. Acad. Sci. USA 103, 13932-13937. (Pubitemid 44452960)
18. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R., Filomeni, G., Di Trapani, G., Clarke, F., Sitia, R., Rubartelli, A. (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99, 1491-1496. (Pubitemid 34136520)
19. Banjac, A., Perisic, T., Sato, H., Seiler, A., Bannai, S., Weiss, N., Kölle, P., Tschoep, K., Issels, R. D., Daniel, P. T., Conrad, M., Bornkamm, G. W. (2008) The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27, 1618-1628. (Pubitemid 351347880)
20. Leichert, L. I., Jakob, U. (2006) Global methods to monitor the thiol disulfide state of proteins in vivo. Antioxid. Redox Signal. 8, 763-772.
21. Harrison, C. A., Raftery, M. J., Walsh, J., Alewood, P., Iismaa, S. E., Thliveris, S., Geczy, C. L. (1999) Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J. Biol. Chem. 274, 8561-8569. (Pubitemid 29164647)
22. Hoppe, G., Talcott, K. E., Bhattacharya, S. K., Crabb, J. W., Sears, J. E. (2006) Molecular basis for the redox control of nuclear transport of the structural chromatin protein HMGB1. Exp. Cell Res. 312, 3526-3538. (Pubitemid 44470773)
23. Kazama, H., Ricci, J. E., Herndon, J. M., Hoppe, G., Green, D. R., Ferguson, T. A. (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29, 21-32. (Pubitemid 351952462)
24. Rubartelli, A., Lotze, M. T. (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28, 429-436. (Pubitemid 47444554)
25. Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E., Sitia, R. (1992) Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267, 24161-24164.
26. Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J., Brown, N., Arai, K., Yokota, T., Wakasugi, H. (1989) ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8, 757-764. (Pubitemid 19273247)
27. Lillig, C. H., Holmgren, A. (2007) Thioredoxin and related molecules - from biology to health and disease. Antioxid. Redox Signal. 9, 25-47. (Pubitemid 44901873)
28. Schwertassek, U., Balmer, Y., Gutscher, M., Weingarten, L., Preuss, M., Engelhard, J., Winkler, M., Dick, T. P. (2007) Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. EMBO J. 26, 3086-3097. (Pubitemid 47057486)
29. Dinarello, C. A. (1998) Interleukin-1, interleukin-1 receptors, and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16, 457-499.
30. Freedberg, I. M., Tomic-Canic, M., Komine, M., Blumenberg, M. (2001) Keratins and the keratinocyte activation cycle. J. Invest. Dermatol. 116, 633-640.
31. Chen, C. J., Kono, H., Golenbock, D., Reed, G., Akira, S., Rock, K. L. (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851-856. (Pubitemid 47038190)
32. Sakurai, T., He, G., Matsuzawa, A., Yu, G. Y., Maeda, S., Hardiman, G., Karin, M. (2008) Hepatocyte necrosis induced by oxidative stress and IL-1 α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14, 156-165.
33. Hazuda, D. J., Strickler, J., Simon, P., Young, P. R. (1991) Structure-function mapping of interleukin 1 precursors. Cleavage leads to a conformational change in the mature protein. J. Biol. Chem. 266, 7081-7086. (Pubitemid 21906334)
34. Rubartelli, A., Cozzolino, F., Talio, M., Sitia, R. (1990) A novel secretory pathway for interleukin-1 β, a protein lacking a signal sequence. EMBO J. 9, 1503-1510. (Pubitemid 20137006)
35. Perregaux, D. G., McNiff, P., Gabel, C. A. (2000) ATP acts as an agonist to promote stimulus-induced secretion of IL-1 β and IL-18 in human blood. J. Immunol. 165, 4615-4623. (Pubitemid 30795843)
36. Andrei, C., Dazzi, C., Lotti, L., Torrisi, M. R., Chimini, G., Rubartelli, A. (1999) The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10, 1463-1475. (Pubitemid 29230902)
37. Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R., Rubartelli, A. (2004) Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. USA 101, 9745-9750. (Pubitemid 38869307)
38. Martinon, F., Petrilli, V., Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241. (Pubitemid 43372104)
39. Fritz, J. H., Ferrero, R. L., Girardin, S. E. (2006) Nod-like proteins in immunity, inflammation, and disease. Nat. Immunol. 7, 1250-1257.
40. Piccini, A., Carta, S., Tassi, S., Lasiglié, D., Fossati, G., Rubartelli, A. (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 105, 8067-8072. (Pubitemid 351904709)
41. Pétrilli, V., Dostert, C., Tschopp, J. (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19, 615-622. (Pubitemid 350236810)
42. Yang, C. S., Shin, D. M., Jo, E. K. (2008) ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signaling. Cell. Microbiol. 10, 741-754.
43. Park, H. S., Jung, H. Y., Bae, Y. S. (2004) Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173, 3589-3593.
44. Lee, J. G., Lee, S. H., Baek, S. H. (2008) Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling. Cell. Signal. 20, 105-111.
45. Hewinson, J., Moore, S. F., MacKenzie, A. B. (2008) A key role for redox signaling in rapid P2X7 receptor-induced IL-1 β processing in human monocytes. J. Immunol. 180, 8410-8420.
46. Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L., Persechini, P. M., Ojcius, D. M. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282, 2871-2879. (Pubitemid 47084344)
47. Dostert, C., Pétrilli, V., Tschopp, J. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677. (Pubitemid 351928351)
48. Meissner, F., Molawi, K., Zychlinsky, A. (2008) Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 9, 866-872.
49. Tassi, S., Carta, S., Vené, R., Delfino, L., Ciriolo, M. R., Rubartelli, A. (2009) Pathogen-induced interleukin-1β processing and secretion is regulated by a biphasic redox response. J. Immunol., in press.
50. Ishii, T., Sugita, Y., Bannai, S. (1987) Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell. Physiol. 133, 330-336. (Pubitemid 18000329)
51. Ohmori, H., Yamamoto, I. (1981) Activation of murine lymphocytes by 2-mercaptoethanol and related thiol compounds and its mechanism. I. Relationship between mitogenic activities and augmenting effects on antibody synthesis in vitro. Immunopharmacology 3, 333-345.
52. Castellani, P., Angelini, G., Delfino, L., Matucci, A., Rubartelli, A. (2008) The thiol redox state of lymphoid organs is modified by immunization: role of different immune cell populations. Eur. J. Immunol. 38, 2419-2425.
53. Ceccarelli, J., Delfino, L., Zappia, E., Castellani, P., Borghi, M., Ferrini, S., Rubartelli, A. (2008) The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to to prooxidants. Int. J. Cancer 123, 1770-1778.
54. Matsue, H., Edelbaum, D., Shalhevet, D., Mizumoto, N., Yang, C., Mummert, M. E., Oeda, J., Masayasu, H., Takashima, A. (2003) Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171, 3010-3018. (Pubitemid 37093524)
55. Mantegazza, A. R., Savina, A., Vermeulen, M., Pérez, L., Geffner, J., Hermine, O., Rosenzweig, S. D., Faure, F., Amigorena, S. (2008) NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112, 4712-4722.
56. Reth, M. (2002) Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3, 1129-1134. (Pubitemid 35469696)
57. Masciarelli, S., Sitia, R. (2008) Building and operating an antibody factory: redox control during B to plasma cell terminal differentiation. Biochim. Biophys. Acta 1783, 578-588.
58. Gross, E., Sevier, C. S., Heldman, N., Vitu, E., Bentzur, M., Kaiser, C. A., Thorpe, C., Fass, D. (2006) Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc. Natl. Acad. Sci. USA 103, 299-304. (Pubitemid 43122395)
59. Tu, B. P., Weissman, J. S. (2002) The FAD- and O(2)-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol. Cell 10, 983-994.
60. Vakkila, J., Lotze, M. T. (2004) Inflammation and necrosis promote tumor growth. Nat. Rev. Immunol. 4, 641-648. (Pubitemid 39025049)
61. Karin, M., Greten, F. R. (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759. (Pubitemid 41400849)
62. Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., Devera, M. E., Liang, X., Tör, M., Billiar, T. (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 220, 60-81. (Pubitemid 350045579)
63. Hussain, S. P., Hofseth, L. J., Harris, C. C. (2003) Radical causes of cancer. Nat. Rev. Cancer 3, 276-285.
64. Cabello, C. M., Bair III, W. B., Wondrak, G. T. (2007) Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr. Opin. Investig. Drugs 8, 1022-1037.
65. Lawenda, B. D., Kelly, K. M., Ladas, E. J., Sagar, S. M., Vickers, A., Blumberg, J. B. (2008) Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J. Natl. Cancer Inst. 100, 773-783. (Pubitemid 351809666)
66. Soini, Y., Kahlos, K., Näpänkangas, U., Kaarteenaho-Wiik, R., Säily, M., Koistinen, P., Pääakkö, P., Holmgren, A., Kinnula, V. L. (2001) Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin. Cancer Res. 7, 1750-1757. (Pubitemid 32708645)
67. Tomiyasu, M., Yoshino, I., Suemitsu, R., Okamoto, T., Sugimachi, K. (2002) Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin. Cancer Res. 8, 3755-3760. (Pubitemid 35424766)
68. Yoo, M. H., Xu, X. M., Carlson, B. A., Gladyshev, V. N., Hatfield, D. L. (2006) Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J. Biol. Chem. 281, 13005-13008.
69. Lu, J., Chew, E. H., Holmgren, A. (2007) Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc. Natl. Acad. Sci. USA 104, 12288-12293. (Pubitemid 47206130)
70. Arner, E. S. J., Holmgren, A. (2006) The thioredoxin system in cancer. Semin. Cancer Biol. 16, 420-426.
71. Powis, G., Kirkpatrick, D. L. (2007) Thioredoxin signaling as a target for cancer therapy. Curr. Opin. Pharmacol. 7, 392-397. (Pubitemid 47289261)
72. Blakytny, R., Erkell, L. J., Brunner, G. (2006) Inactivation of active and latent transforming growth factor β by free thiols: potential redox regulation of biological action. Int. J. Biochem. Cell Biol. 38, 1363-1373.
73. Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., Lotze, M. T. (2007) Masquerader: high mobility group box-1 and cancer. Clin. Cancer Res. 13, 2836-2848. (Pubitemid 46850704)
74. Heighway, J., Knapp, T., Boyce, L., Brennand, S., Field, J. K., Betticher, D. C., Ratschiller, D., Gugger, M., Donovan, M., Lasek, A., Rickert, P. (2002) Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21, 7749-7763. (Pubitemid 35398821)
75. Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., Rabinovich, G. A. (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege. Cancer Cell 5, 241-251. (Pubitemid 38402116)
76. Scaffidi, P., Misteli, T., Bianchi, M. E. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195. (Pubitemid 34773774)
77. Rajewsky, K. (1996) Clonal selection and learning in the antibody system. Nature 381, 751-758. (Pubitemid 26243107)
78. Mariathasan, S., Monack, D. M. (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7, 31-40. (Pubitemid 46020825)
79. Hreggvidsdottir, H. S., Ostberg, T., Wahamaa, H., Schierbeck, H., Avenberger, A. C., Klevenvall, L., Palmblad, K., Ottoss, L., Andersson, U., Erlandsson Harris, H. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86, 655-662.
80. Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C. A., Apte, R. N. (2007) Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67, 1062-1071. (Pubitemid 46270762)